Aileron Therapeutics Inc (ALRN)
3.76
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Aileron Therapeutics Shareholders Equity (Quarterly): 6.887M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.887M |
| September 30, 2023 | 11.20M |
| June 30, 2023 | 12.79M |
| March 31, 2023 | 14.27M |
| December 31, 2022 | 18.62M |
| September 30, 2022 | 22.70M |
| June 30, 2022 | 28.62M |
| March 31, 2022 | 36.11M |
| December 31, 2021 | 43.90M |
| September 30, 2021 | 50.11M |
| June 30, 2021 | 56.13M |
| March 31, 2021 | 61.42M |
| December 31, 2020 | 12.16M |
| September 30, 2020 | 12.46M |
| June 30, 2020 | 16.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.769M |
| December 31, 2019 | 16.05M |
| September 30, 2019 | 22.82M |
| June 30, 2019 | 29.98M |
| March 31, 2019 | 12.85M |
| December 31, 2018 | 19.60M |
| September 30, 2018 | 26.03M |
| June 30, 2018 | 32.87M |
| March 31, 2018 | 40.98M |
| December 31, 2017 | 47.80M |
| September 30, 2017 | 54.01M |
| June 30, 2017 | -120.78M |
| March 31, 2017 | 14.28M |
| December 31, 2016 | -111.81M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.887M
Minimum
Dec 2023
61.42M
Maximum
Mar 2021
25.40M
Average
18.62M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 266.32M |
| INVO Bioscience Inc | 0.8928M |
| Bio-Path Holdings Inc | 0.441M |
| SINTX Technologies Inc | 8.772M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.01M |
| Total Liabilities (Quarterly) | 99.12M |